Applied dna reports 2020 year end and fiscal fourth quarter financial results

Stony brook, n.y.--(business wire)---- $apdn #covid19--applied dna sciences, inc. (nasdaq: apdn) (“applied dna” or the "company"), a leader in polymerase chain reaction (pcr)-based dna manufacturing, today announced consolidated financial results for the full fiscal year and quarter ended september 30, 2020. “our activities in fiscal 2020 were principally devoted to the establishment of our diagnostic and surveillance testing programs for covid-19 and to further positioning our proprietary lineardna™ manufacturin
APDN Ratings Summary
APDN Quant Ranking